178 results on '"Hatakeyama, Shinji"'
Search Results
2. Good Submission Practice
Catalog
Books, media, physical & digital resources
3. Identification and characterization of a phenyl-thiazolyl-benzoic acid derivative as a novel RAR/RXR agonist
4. Formation of Ge dot or film in Ge/Si heterostructure by using sub-monolayer carbon deposition on top and in-situ post annealing
5. A novel tissue-selective β2-adrenoceptor agonist with minimized cardiovascular effects, 5-HOB, attenuates neuropathic pain in mice
6. Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models
7. Evaluation of therapeutic effects of FAK inhibition in murine models of atherosclerosis
8. Supplementary Table 1 from Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo
9. Supplementary Table S1 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
10. Data from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
11. Formation of Ge dots on Si(100) using reaction of Ge with sub-monolayer carbon on top
12. Correction: Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle.
13. Formation of Ge quantum dots on Si substrate using consecutive deposition of Ge/C and in situ post annealing
14. Transition of carbon binding states on Si(1 0 0) depending on substrate temperature and its effect on Ge growth
15. Structural transition in Ge growth on Si mediated by sub-monolayer carbon
16. In silico labeling enables kinetic myelination assay in brightfield
17. Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma
18. Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo
19. Degenerative Joint Disease Induced by Repeated Intra-Articular Injections of Monosodium Urate Crystals in Rats as Investigated by Translational Imaging
20. Analyses of Group III Secreted Phospholipase A2 Transgenic Mice Reveal Potential Participation of This Enzyme in Plasma Lipoprotein Modification, Macrophage Foam Cell Formation, and Atherosclerosis
21. Group IVA phospholipase A 2 is associated with the storage of lipids in adipose tissue and liver
22. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
23. JTB: A novel membrane protein gene at 1q21 rearranged in a jumping translocation
24. Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy
25. Therapeutic potential of muscle growth promoters in a stress urinary incontinence model
26. Mouse models of cancer-induced cachexia: Hind limb muscle mass and evoked force as readouts
27. MOESM1 of Evaluation of therapeutic effects of FAK inhibition in murine models of atherosclerosis
28. MOESM2 of Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models
29. Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia
30. PD36-10 BLOCKADE OF ACTIVIN TYPE II RECEPTORS WITH BIMAGRUMAB INCREASES THE URETHRAL PRESSURE IN A DUAL MUSCLE AND NERVE INJURY STRESS URINARY INCONTINENCE MODEL
31. Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies
32. Variant forms of upstream stimulatory factors (USFs) control the promoter activity of hTERT, the human gene encoding the catalytic subunit of telomerase
33. Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia.
34. Additional file 1: Figure S1. of ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments
35. Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
36. Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
37. ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments
38. TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells
39. Transition of carbon binding states on Si(100) depending on substrate temperature and its effect on Ge growth
40. Mediation effect of sub-monolayer carbon on interfacial mixing in Ge growth on Si(100)
41. An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
42. 痛み情報伝達における膜電位依存性N型カルシウムチャネルの役割に関する研究
43. Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle
44. PROPOSAL CONCERNING EFFECTIVENESS MORTGATE OF ENTERPRISE BCP BASED ON RESILIENCE'S IDEA
45. A PROPOSAL OF CONCEPT OF BCP AND DISATER MITIGATION AS WELL AS DISATER PREVENTION FOR LOCAL GOVERNMENT BASED ON RESILIENCE
46. 痛み情報伝達における膜電位依存性N型カルシウムチャネルの役割に関する研究
47. AN APPROACH FOR COMMUNITY CONTINUITY PLAN BASED ON COMMUNITY RESILIENCE CONCEPT
48. DRAWING CONCEPT OF COMPANY BCP WITH CONSIDERING DISTRICT CONTINUITY AND PROPOSE OF MEASURES FOR REINFORCING DISASTER RESILIENCE
49. Blockade of the Activin Receptor IIB Activates Functional Brown Adipogenesis and Thermogenesis by Inducing Mitochondrial Oxidative Metabolism
50. YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.